IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion

Genes and Development - Tập 24 Số 3 - Trang 241-255 - 2010
Vasilena Gocheva1, Hao‐Wei Wang1, Bedrick B. Gadea1, Tanaya Shree1, Karen E. Hunter1, Alfred L. Garfall1, Tara Berman1, Johanna A. Joyce1
1Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA

Tóm tắt

Innate immune cells can constitute a substantial proportion of the cells within the tumor microenvironment and have been associated with tumor malignancy in patients and animal models of cancer; however, the mechanisms by which they modulate cancer progression are incompletely understood. Here, we show that high levels of cathepsin protease activity are induced in the majority of macrophages in the microenvironment of pancreatic islet cancers, mammary tumors, and lung metastases during malignant progression. We further show that tumor-associated macrophage (TAM)-supplied cathepsins B and S are critical for promoting pancreatic tumor growth, angiogenesis, and invasion in vivo, and markedly enhance the invasiveness of cancer cells in culture. Finally, we demonstrate that interleukin-4 (IL-4) is responsible for inducing cathepsin activity in macrophages in vitro and in vivo. Together, these data establish IL-4 as an important regulator, and cathepsin proteases as critical mediators, of the cancer-promoting functions of TAMs.

Từ khóa


Tài liệu tham khảo

10.1042/bj2820273

10.1016/j.ccr.2009.06.018

10.1073/pnas.85.23.9037

10.1101/gad.1407406

10.1158/0008-5472.CAN-04-1853

10.1074/mcp.T100003-MCP200

Guy, 1992, Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease, Mol Cell Biol, 12, 954

10.1172/JCI9411

10.1038/315115a0

10.1177/002215540004801012

10.1074/jbc.272.46.29190

10.1038/nrc2618

10.1016/S1535-6108(04)00111-4

10.1093/ndt/gfp045

10.1126/science.1948049

10.1007/BF01753666

10.1158/0008-5472.CAN-08-0449

10.1038/nm.1927

10.1016/S0002-9440(10)63568-7

Lindahl, 2009, Increased levels of macrophage-secreted cathepsin S during prostate cancer progression in TRAMP mice and patients, Cancer Genomics Proteomics, 6, 149

10.1016/S1535-6108(02)00055-7

10.1038/nature07205

10.1146/annurev.immunol.021908.132532

10.1038/nrc1949

10.1038/nrc2444

10.1046/j.1365-2249.1998.00576.x

10.1016/S0014-5793(97)00313-X

10.1111/j.1399-0039.2007.00831.x

10.1016/j.tips.2007.10.011

10.1073/pnas.96.15.8627

10.1038/nrc1256

10.1038/sj.bjc.6602416

10.1096/fj.99-0970com

10.1016/S1074-7613(00)80020-5

10.1038/ncb1288

10.1016/S0022-1759(99)00240-9

10.1016/j.iac.2004.06.008

10.1002/ijc.24275

10.1146/annurev.pathol.1.110304.100224

10.1016/j.stem.2007.08.001

10.1038/sj.cdd.4402305

Topp, 1995, Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies, Cancer Res, 55, 2173

10.1158/0008-5472.CAN-05-4463

10.2174/138161207780162962

10.1074/jbc.M509134200

10.1097/00002371-199811000-00006

10.1097/00002371-200207000-00007

10.1158/0008-5472.CAN-04-1449